We report a detailed study of AQP4 expression in the neuromuscular system of mdx mice. Immunocytochemical analysis performed by double immunostaining revealed that mdx mice manifest a progressive reduction in AQP4 at the sarcolemmal level of skeletal muscle fast fibers and that type IIB fibers are the first to manifest this reduction in AQP4 expression. No labeling was observed in the cytoplasm of muscle fibers, indicating that the reduction in sarcolemma staining is not associated with an intracellular compartmentalization of mistargeted protein. By Western blot and RT-PCR analysis, we found that whereas the total content of AQP4 protein decreased (by 90% in adult mdx mice), mRNA levels for AQP4 remained unchanged. A similar agerelated reduction in AQP4 expression was found in brain astrocytic end-feet surrounding capillaries of mdx mice. Morphometric analysis performed after immunogold electron microscopy indicated a reduction of ϳ85% in gold particles (32؎2/m vs. 4.7؎0.61/m). Western blot experiments conducted using membrane fractions from brain cortex revealed a strong reduction (of 70%) in AQP4 protein in adult mdx mice, and RT-PCR experiments demonstrated that the reduction was not at transcription level. More interesting was the finding that AQP4 reduction was associated with swelling of astrocytic perivascular processes whose ultrastructural modifications are commonly indicated as an important and early event in the development of brain edema. No apparent reduction in AQP4 was found in mdx stomach and kidney. Our data provide evidence that dystrophin deficiency in mdx mice leads to disturbances in AQP4 assembly in the plasma membrane of fast skeletal muscle fibers and brain astrocytic end-feet, suggesting that changes in the osmotic equilibrium of the neuromuscular apparatus may be involved in the pathology of muscular dystrophy.-Frigeri, A., Nicchia, G. P., Nico, B., Quondamatteo, F., Herken, R., Roncali, L., Svelto, M. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J.
boys, causing progressive muscle fiber degeneration and death. In addition to muscular weakness, one-third of patients suffering from DMD exhibit mental retardation (1) . The product of the gene in the muscle is dystrophin, a 427 kDa protein consisting of four structural domains: an amino-terminal actin binding domain, a central rod region, a cysteine-rich domain, and a carboxyl-terminal domain (2) . In normal muscle fibers, dystrophin is associated with the sarcolemma via a membrane-spanning glycoprotein complex of dystrophin-associated proteins (DAPs; 3). The sarcolemmaspanning complex is proposed to link the extracellular matrix components to the membrane cytoskeleton, thereby stabilizing the fiber periphery during muscle contraction (4) . Mutations in any of the proteins within this complex result in muscle fiber instability, leading to muscular dystrophy (5) . The DMD gene also codes for two nonmuscle isoforms of dystrophin: the braintype dystrophin and the Purkinje cell-type dystrophin transcribed by different promoters (6) . Moreover, internal promoters in the huge DMD gene regulate the expression of four smaller proteins differing in their amino-terminal domains (7) .
Much of the information about the precise mechanism by which the absence of dystrophin leads to muscle cell necrosis comes from the dystrophin-deficient mdx mouse. This animal model has a genetic defect in the homologous region to the human DMD gene (8) and similarly lacks the dystrophin protein, but manifests a less severe phenotype.
In both DMD patients and mdx mice, a clear morphological feature of dystrophic muscle fibers is the drastic reduction in orthogonal arrays of particles (OAPs; 9, 10), now shown to be the morphological equivalent of the AQP4 water channel (11, 12) .
In a recent study, we demonstrated the functional expression of a water channel (i.e., AQP4) in the sarcolemma of fast-twitch fibers of skeletal muscle for the first time (13) . Moreover, preliminary results showed a drastic reduction in AQP4 immunolocalization in mdx mouse muscle plasma membrane (13) , indicating a possible involvement of AQP4 in the biochemical alteration of muscle fibers in DMD. It is not known which skeletal muscle fibers are affected, nor whether the drastic reduction in AQP4 water channels is due to a decrease in AQP4 synthesis or to disturbances in AQP4 assembly into the muscle plasma membrane.
The main site of AQP4 expression is, however, the central nervous system. In particular, AQP4 has been localized in astrocytic end-feet, as well as in ependymal cells where OAPs have been found (14, 15) . It has been proposed that AQP4 plays an important role in controlling water movement between blood and brain, thus maintaining the osmotic balance of the brain (16) .
Furthermore, in mdx brain, biochemical analysis has shown an increased extracellular and decreased intracellular brain volume (17) , but no findings on OAP alterations (i.e., changes to the AQP4 water channel) have been reported. Therefore, in the present study we investigated whether the alteration in intracellular brain volume reported in mdx mice may be due to an alteration in AQP4 expression and/or assembly.
Our results indicate that an important reduction in AQP4 protein content is found in the neuromuscular system of the dystrophic animal. This reduction, at least in the brain, is clearly associated with an altered water balance, as indicated by the presence of swollen glial processes.
MATERIALS AND METHODS

Animals
Female mdx (C57BL10 ScSn mdx) and control mice (C57BL10 ScSn) were supplied by the animal facility of the Policlinico Gemelli (courtesy of Dr. R. Filippetti, Catholic University of Rome, Italy). The mice were killed by cervical dislocation and their bilateral tibialis anterior and soleus muscles were excised. Three to seven animals for each condition were used.
Immunocytochemistry
Immunofluorescence
Mouse muscles were dissected and rapidly frozen in isopentane cooled with liquid nitrogen. Cryostat 5 m cross sections were incubated at the same time with affinity-purified (0.3-0.5 g/ml) rabbit AQP4 antibodies (13) and with IIA or IIB (18) or I type (Sigma, St. Louis, Mo.) myosin heavy chain (MHC) mouse monoclonal antibodies for 1 h at room temperature. After washings, sections were incubated for 1 h with CY3-coupled goat anti-rabbit and FITC-coupled goat anti-mouse antibodies. Sections were examined with a Leica DMRXA photomicroscope equipped for epifluorescence, and digital images were obtained with a cooled CCD camera (Princeton Instruments, Princeton, N.J.). The specificity of the AQP4 antibody used in this study was previously reported (13, 14) .
Immunoperoxidase
Brains were dehydrated in an ascending ethanol series and embedded in paraffin. Five micrometer sagittal sections were collected on polylysine-coated slides and deparaffinized. After blocking, the sections were sequentially incubated with 1) primary rabbit affinity-purified anti-AQP4 antibody (0.3-0.5 g/ml) diluted in TBS overnight at 4°C; 2) secondary antibody, goat anti-rabbit (Dakopats, Hamburg, Germany) diluted 1:50 in TBS for 30 min at room temperature, followed by the PAP complex, using commercial reagents (Dakopats). Finally, the sections were treated with 0.06% 3,3Ј diaminobenzidine in Tris-HCl buffer in the presence of H 2 O 2 and counterstained with Mayer's hematoxylin for 1 min. Control experiments performed using immunodepleted antibodies showed no staining.
Immunogold electron microscopy
Small pieces of brain cortex were fixed in 1% glutaraldehyde and embedded in the acrylic resin LR-Gold (Bio-Rad, Richmond, Calif.) with 0.8% benzil. Thin sections (60 nm) cut with an LKB V ultramicrotome were incubated for 10 min at room temperature with TBS buffer; unspecific binding sites were blocked with 1% bovine serum albumin-TBS, pH 7.4, for 10 min at room temperature. The sections were incubated with the primary antibody (affinity-purified anti-AQP4, 0.3-0.5 g/ml) at room temperature overnight, washed with TBS, and incubated for 1 h at room temperature with the second antibody (goat anti-rabbit) coupled with 6 nm gold particles (Chemicon Intern. Inc., S.I.C., Rome, Italy). After washing with TBS, the grids were stained with 1% uranyl acetate, followed by 1% lead citrate, and examined with a Zeiss EM 109 electron microscope (Zeiss, Oberkochen, Germany).
Quantification of AQP4 gold particle distribution
To quantify AQP4 gold particle distribution on the glial end-feet facing the microvessels, 198 electron micrographs at the final magnification of ϫ30,000 were chosen for control and for mdx brain mouse frontal cortex. The number of particles distributed along the total length of the abluminal microvessels side (basement membrane and glial end-feet) was counted with the use of an electronic pen connected to a graphic tablet (Digicad Plus Kontron-Elektronic, GMBH, Germany) and to a VIDAS 2.5 computerized image analyzer (Kontron Elektronic). One hundred thirty-five vessel profiles were analyzed for four mdx mice and 65 for three control mice. The results were expressed as the number of gold particles per micrometer of microvessels abluminal front. The mean value in each case, the final mean value for all controls and for the mdx mouse brains, and the standard deviation were calculated for each variable. The statistical significance of the difference between the mean values of the number of gold particles and between the luminal and abluminal surfaces of the endothelial cells was determined by the Student's t test for unpaired data.
AQP4 immunoprecipitation from mouse muscle
Skeletal mouse muscle was cut into small pieces and homogenated in incubation buffer (2% Triton X-100 and 0.5% Nonidet P-40 in 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, MgCl 2 , and CaCl 2 ) using a Heidolph homogenizer (max speed for 10 s). After homogenization, the sample was incubated on ice for 2 h under agitation. The extract was then centrifuged at 12,000 g for 5 min; 3 mg of the supernatant was mixed with 3 l of AQP4 immune serum and incubated for 4 h at 4°C. Pre-swollen protein A-Sepharose beads were then added to the sample and incubated for 1 h. The beads were collected by centrifugation, washed several times with washing buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, MgCl 2 , and CaCl 2 ), and finally resuspended in Laemmli sample buffer. The recovered proteins were analyzed by Western blot.
Preparation of brain membrane fraction
Mouse brains were homogenized in 300 mM mannitol and 12 mM HEPES-Tris, pH 7.4. After homogenization in a Potter apparatus, the sample was centrifuged at 100 g. The supernatant was then analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot.
Western blot analysis
SDS-PAGE was performed as described previously (13) . AQP4 protein was revealed by enhanced chemiluminescence (ECLϩplus, Amersham, Little Chalfont, U.K.). Coomassiestained gels and ECL film were scanned using a UMAX SPEED IIC scanner and Adobe Photoshop software. Densitometric analysis was performed using Scion Image software, and AQP4 protein levels in mdx mice were expressed as fractions of the respective levels in control mice. The statistical analysis was conducted by the Student's t test for unpaired data.
Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
Tibialis anterior, soleus, and brain RNA was prepared using the TRIzol reagent (Gibco-Life Technologies, Inc., Grand Island, N.Y.) and cDNAs were prepared using random primers. The cDNAs were used to amplify a 610 bp fragment using specific primers (sense 5Ј-ATGGTGGCTTTCAAAGGGGT-3Ј; antisense 5Ј-GATGGGCCCAACCCAATATAT-3Ј) for the AQP4 sequence (19, 20) . Relative amounts of AQP4 transcript were estimated by direct comparison between multiple samples after standardization with coamplification of 18S rRNA (QuantumRNA kit, Ambion, Austin, Tex.). Densitometric analysis was performed as reported for the Western blot experiments. The statistical analysis was conducted by the Student's t test for unpaired data.
RESULTS
Immunoanalysis of AQP4 expression in fast-twitch fibers
We recently reported that AQP4 is strongly expressed in the sarcolemma of fast-twitch muscle fibers and that its expression is drastically reduced in mdx mice (13) . To determine precisely which fibers are affected, we first investigated the expression of AQP4 in the skeletal muscle of control mice using affinity-purified AQP4 antibody together with specific antibodies against slow (type I) and fast (type IIA, IIB) MHC isoforms. Figure  1 shows double immunostaining experiments in soleus (slow muscle) and tibialis anterior (fast muscle). In soleus, type IIA fibers were stained (Fig. 1A ) whereas fibers that contained type I MHC were negative for AQP4 immunostaining (Fig. 1B) . Using tibialis anterior muscle, we found that both type IIB (Fig. 1D ) and type IIA fibers (Fig. 1C ) expressed the AQP4 water channel. These results show that the expression of AQP4 in mouse skeletal muscle is restricted to fast contracting fibers and seems related to the glycolitic metabolism of the fiber.
Analysis of AQP4 in the tibialis anterior of the mdx mouse
AQP4 sarcolemma staining in the tibialis anterior of mdx mice is progressively reduced. In young mdx mice (1 month old), type IIB fibers were more affected than type IIA fibers. Although numerous type IIA fibers appeared to have quite a normal sarcolemmal AQP4 staining ( Fig. 2A) , the majority of type IIB fibers underwent a progressive reduction in staining (Fig.  2B ). Our results show that a subset of fast fibers, the type IIB fibers, are the first to manifest a reduction in AQP4 staining. In adult mdx mice (1 year old), the reduction in AQP4 staining was more general. Both type IIA (Fig. 2C ) and type IIB (Fig. 2D) fibers manifest a drastic reduction in AQP4 staining. In many areas of tibialis anterior, only a weak fluorescence signal was detected on some fibers. Immunofluorescence analysis indicates that the number of AQP4-positive fibers in 1-month-old mdx mice represent 70% (PϽ0.01, nϭ5) of the AQP4-expressing fibers in control mice whereas only 8% (PϽ0.001, nϭ5) of 1-year-old mdx mice show a weak immunofluorescence labeling. No labeling was observed in the cytoplasm of muscle fibers. We next used immunoprecipitation experiments to examine whether the reduction in sarcolemma staining was caused by an improper assembly of AQP4 protein in the membrane and/or a reduction in protein content. Immunoprecipitated proteins were analyzed by immunoblot. Compared to age-matched control mice, AQP4 protein is reduced by 20% (PϽ0.01, nϭ3) and 90% (PϽ0.001, nϭ4) in 1-month-and 1-year-old mdx mice, respectively (Fig. 3B) . Coomassie blue-stained gels showed that the overall protein band pattern is relatively comparable between normal mouse and mdx skeletal muscle homogenates (Fig. 3A) . Thus, necrosis in mdx muscle fibers does not seem to trigger general proteolitic degradation of bulk skeletal muscle protein.
Instead, the loss of dystrophin seems to cause a specific reduction in AQP4 protein content.
To determine whether the reduction in the amount of AQP4 protein in the skeletal muscle of mdx mice was caused by changes at the level of AQP4 mRNA, we performed semi-quantitative RT-PCR experiments (Fig.  3E) . The amount of AQP4-PCR product was analyzed together with the amplification of 18S RNA, an invariant internal standard. Results showed that the level of AQP4-PCR product in mdx mice was similar to that of control mice (PϾ0.5, nϭ4) indicating that the AQP4 mRNA level does not change significantly during the progression of muscle pathology. Looked at together, these results show that, in the skeletal muscle of mdx mice, AQP4 expression is progressively reduced with the age of the animal and that this reduction does not occur at transcription level.
Evaluation of AQP4 expression in mdx mouse brain
Western blot and RT-PCR
Since the mdx mouse brain metabolism is abnormal and associated with an increase in extracellular volume (17), we next evaluated whether changes in AQP4 expression also occur in the brain. Coomassie bluestained gels showed that the overall protein band pattern exhibits no major differences between normal and pathological specimens (Fig. 3C) , indicating that general proteolitic degradation does not occur in dystrophic brain. AQP4 protein expression was evaluated by densitometric analysis of immunoblot experiments using a membrane fraction of brain homogenate. AQP4 content was progressively reduced with age in mdx mice. Compared to control mice, AQP4 protein in the brain is reduced by 30% (PϽ0.01, nϭ4) in 1-monthold mice. Strong reductions were observed in 1-year-old animals (70%) (PϽ0.001, nϭ7) compared to the agematched control (Fig. 3D ). AQP4 mRNA levels in the brain were analyzed by RT-PCR experiments. The re- sults showed no significant differences (PϾ0.5, nϭ4) in the amounts of AQP4 PCR product in both control and dystrophic mice, indicating that the reduction in AQP4 in dystrophic brain mice was not at transcription level (Fig. 3E) .
Immunocytochemistry
Immunohistochemistry experiments were performed in order to evaluate the site of AQP4 alterations in the brain. At light microscopy, the observation carried out on the immunostained sections showed that the cytochemical localization of AQP4 in mdx mice brain was similar to that in the controls, whereas in the former the reaction intensity was diminished. The immunocytochemical analysis carried out in the brain of control mice, including telencephalon, diencephalon, and mesencephalon, showed that the anti-AQP4 antibody exclusively stained bodies and processes of astrocytic cells, forming a dense glial network throughout the neuropile and a continuous layer around the vessels. These vessels showed a marked, continuous staining along the abluminal side; labeled bodies and processes of glial cells were recognizable, even close to the endothelium-pericyte layer ( Fig. 4A-E) . In 1-year-old mdx mice, the bodies and processes of astrocytes scattered in the neuropile appeared weakly AQP4 immunolabeled, and a remarkable labeling reduction was also observed in the perivascular glial end-feet ( Fig.  4G-K) . The perivascular staining was point-by-point and discontinuous, labeled vascular tracts alternating with unlabeled ones. The walls of some vessels appeared quite unlabeled. In normal mice, a strong AQP4 immunoreaction was recognizable in the glial-limiting membrane formed by the astrocyte end-feet in the submeningeal region (Fig. 4A) , whereas the submeningeal glial limiting membranes of mdx brain showed a slight AQP4 expression or appeared completely unstained (Fig. 4G) .
The brain osmosensory regions of control mice, including hypothalamic magnocellular nuclei (Fig. 4D , E) and circumventricular organs, showed strong AQP4 glial immunolabeling, especially at perivascular level, whereas the neuronal cells, including the magnocellular neurons in the paraventricular and supraopticus hypothalamic nuclei, appeared completely unlabeled. In the diencephalic brain regions of the mdx mice, including the osmosensory areas, the AQP4 labeling appeared remarkably reduced. The glial processes distributed throughout the neuropile and perivascularly arranged were scantily stained, so that the brain parenchyma and vessel walls displayed a weak labeling (Fig.  4I-K) .
A noticeable AQP4 reduction was observed in the periventricular epithelium whose basolateral cellular membranes as well as the subependymal layer glial cells appeared unstained or scarcely marked (Fig. 4L) , whereas in the control brain the ependymal epithelium appeared heavily labeled by anti-AQP4 antibody ( Note that the subependymal layer (asterisk) is quite unlabeled compared to the control (F). Original magnification: A, ϫ200; B, ϫ800; C, ϫ800; D, ϫ400; E, ϫ1000; F, ϫ800; G, ϫ300; H, ϫ850; I, ϫ800; J, ϫ350; K, ϫ1000; L, ϫ800. 4F). Similar results were obtained with four different samples.
All the localization sites of AQP4 expression in mouse brain were identical to those reported for rat brain (14, 15, 19 -21,) .
Immunogold electron microscopy confirmed the expression of astrocyte bodies and processes. The astrocytic processes closely arranged around the blood vessels were intensely labeled. Numerous 6 nm gold particles, isolated or clustered, were seen on the membranes of the astrocytic perivascular processes facing the capillaries (Fig. 5A) . On the ultrathin sections of mdx brain, the immunogold reaction revealed a small number of AQP4 gold particles attached to the bodies and processes of astrocytes. A strong reduction in labeling was also observed in the glial end-feet facing the blood vessels. These were surrounded by strongly swollen astrocytic processes whose plasma membranes showed very rare, isolated gold particles (Fig. 5B) . Morphometric analysis of immunogold labeling indicated a ϳ85% reduction in gold particles (32Ϯ2/m vs. 4.7Ϯ0.61/m, PϽ0.001, nϭ4). No labeling of intracellular compartments was detected; the reduced AQP4 protein levels are thus not a consequence of altered protein distribution within the cell.
Analysis of AQP4 expression in other mdx mouse tissues
To assess whether the reduction in AQP4 involves other tissues in which this aquaporin is expressed (14, 21), we investigated AQP4 expression level in the kidney and stomach of mdx mice. Immunofluorescence analysis indicated no major modifications of AQP4 expression in the oxyntic glands of the lower stomach (Fig. 6A) with a regular staining of the basolateral membrane of parietal cells (Fig. 6B ), but not of the chief cells. Normal staining was also observed in mdx mouse kidney. The medullary collecting ducts all appeared to be intensely labeled by AQP4 antibodies (Fig. 6C ) and retained the specific staining of the basolateral membrane of principal cells (Fig. 6D) .
DISCUSSION
We recently demonstrated that AQP4 is functionally expressed in the sarcolemma of fast-twitch fibers and reported a preliminary result on AQP4 expression in mdx mouse skeletal muscle (13) . Thus, the purpose of this study was to analyze the expression of AQP4 in mdx mice, with particular regard to skeletal muscle and brain of dystrophic mdx mice, and to determine whether AQP4 expression in brain could also be affected in such animal models. Our immunofluorescence results showed that AQP4 reduction in skeletal muscle is progressive and begins by involving a subset of fast-twitch fibers identified as type IIB. The immunofluorescence and immunoblotting results together with quantitative PCR data indicate that AQP4 reduction seems to be related to a premature protein degradation. In fact, the AQP4 mRNA content was found to be unchanged, indicating that the protein reduction is at posttranslational level. Moreover, since the reduction in sarcolemma staining was not accompanied by an increase in intracellular labeling and the content of AQP4 protein was reduced in the whole muscle homogenate, we can conclude that the reduction in sarcolemma staining is not associated with an intracellular compartmentalization of mistargeted protein.
Many studies have analyzed the water and ion concentration in muscle (22, 23) . These studies have demonstrated that the contractile cycle appears to be associated with water entry into and exit from the cell. In fact, during muscle exercise, there is a rapid flux of water from the vascular compartment into contracting muscles, due to an increase in intracellular osmolytes such as lactate (24) . This water displacement may affect the membrane potential and thus muscle membrane excitability. Thus, AQP4 determining a rapid osmotic transfer of water from blood to muscle during contraction would therefore be important in establishing muscle fatigue and so protect the cells against overload.
As demonstrated by the present study, mdx mice fast fibers progressively reduce the sarcolemma expression of AQP4 protein. The reduction seems to involve type IIB first and subsequently type IIA. This is confirmed by analyzing the tibialis anterior fibers of 1-year-old mdx mice, where a weak residue of AQP4 labeling was only associated with type IIA fibers. Normally dystrophin is expressed in all myofiber types (25) ; nevertheless, type IIB fibers are preferentially affected in DMD patients (26) . Although the mechanisms underlying this pathology remain to be determined, it is possible that type IIB fibers are more sensitive to dystrophin deficiency than others, and this may have a consequence in the expression of AQP4. A previous study reported that mdx muscle fibers show a decreased osmotic stability compared to normal muscle fibers (27) , but no indications on water content or changes were reported. Other studies report variations in water content in the muscles of mdx mice (28) and dystrophic chicks (29) and significant increases in intracellular water associated with a pronounced type II fiber deficiency in dystrophic canine muscle (30) . We can suspect that the reduced presence of AQP4 in mdx fibers would determine important modifications in the rapid and reversible cell volume equilibration in muscle and thus affect many biological processes.
With respect to the pathophysiological mechanisms that may lead to brain abnormalities in DMD, a deficiency in dystrophin may cause a reduction in other associated proteins, such as the dystroglycan complex (31) . This would render specific regions of the central nervous system more susceptible to cellular disturbances and may result in cognitive impairment in some Duchenne patients. Similar cognitive dysfunction also seems to occur in mdx mice (32) . Furthermore, in mdx mice, a significant increase in extracellular brain volume leading to possible abnormal development has been reported (17, 33) .
In the brain, AQP4 protein is strongly expressed in perivascular astrocyte processes and ependymoglial cells, where it may regulate water permeability at the blood-brain barrier (BBB) and cerebrospinal fluid (CSF) reabsorption at the ventricular side (14, 15, 21) . Therefore, we investigated the expression of AQP4 in dystrophic brains. Our results indicate a marked reduction in AQP4 protein in mdx brain astrocytic processes and ependymoglial cells, and demonstrate that this reduced staining is not due to an altered distribution of AQP4 in the plasma membrane nor to a reduction in AQP4 mRNA content.
It is well known that in several CNS diseases as well as many pathological conditions, BBB injury occurs tightly associated with an increased vascular permeability (for a review, see ref 34) . Moreover, astrocytic cells have been demonstrated to play a control role in BBB exchanges, maintaining CNS homeostasis by a direct or indirect regulation of the ionic flux occurring during neuronal activity with consequent osmotic water redistribution (35) (36) (37) . Therefore, the detection of a drastic AQP4 reduction in the perivascular astrocytic end-feet suggests that in the mdx brain the regulation of the vascular water transport is altered with a probable modification of the cerebral microenvironment and neuronal cell activity. The reduction in AQP4 we found in the brains of mdx mice was often associated with swollen astrocyte processes, suggesting that its function is strictly related to the reabsorption of water from the extracellular fluid to the blood and CSF. This agrees with a recent study on rat brain AQP4 ontogeny, showing that it accumulates in the brain as the volume fraction of the extracellular space rapidly declines (16) . Consequently, the reduction of AQP4 protein in mdx mouse brain would determine a slower drainage of water out of the brain, astrocyte swelling, and cellular brain edema. This conclusion is further supported by a recent study reporting that up-regulation of AQP4 mRNA occurs after brain injury that determined BBB disruption and edema (38) . Another possibility is that the reduction of AQP4 protein in brain may be a consequence of an altered vascular permeability of the BBB barrier.
Dystrophin deficiency results in the depletion of several associated proteins (39) . Moreover, the number of newly discovered dystrophin-associated proteins (40) is making the dystrophin complex more complicated to study (41) . From our data, we can hypothesize that AQP4 in skeletal muscle interacts with other sarcolemma proteins, such as those of the dystrophin glycoprotein complex (DAPs). An accurate analysis of the AQP4 amino acid sequence reveals a carboxyl-terminal tetrapeptide motif X-Ser/Thr-X-Val-COO-, which is known to interact with PDZ domains. The PDZ domain is composed of 90 amino acids and was originally identified in postsynaptic density-95, disc large, and ZO-1 (42) . The PDZ domain is present in diverse families of structural proteins and appears to be involved in the targeting and clustering of membrane proteins. In skeletal muscle there are a few PDZ domain proteins; these include neuronal nitric oxide synthase and the family of syntrophins (42) , both of which are components of the dystrophin complex (43) . In particular, the role of syntrophin in skeletal muscle seems to be to recruit signaling proteins, such as voltage-gated sodium channels, to the membrane (44), thus acting as a modulator adaptor protein. Of all the components of the DAPs complex, syntrophin seems most likely to be the one that interacts with AQP4 in skeletal muscle. This is further supported by a recent study showing that in alpha 1-syntrophin knockout mice, aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte end-feet (45) . Identifying other proteins associated with AQP4 may be particularly relevant in order to understand the molecular origin of the DMD myopathy as well as the physiological role of AQP4 in skeletal muscle.
The reduction in AQP4, which is not seen at transcription level, could be due to a reduced stability of the DAP complex when there is no dystrophin to anchor the complex. Further studies are needed to determine the biochemical relationship between AQP4 and the ensemble of proteins bound to dystrophin in order to determine whether AQP4 contributes directly to the pathogenesis of muscular dystrophy, as occurs with some individual components of the DAP complex. Immunoreactive dystrophin has recently been detected in perivascular astrocytes and its developmental expression coincides with the development of the BBB (46) . Since AQP4 expression seems unaltered in stomach and kidney, this suggests a different membrane organization of this water channel in the neuromuscular system compared to the other epithelial membranes in which this water channel is expressed. A recent study (47) demonstrating that other AQP4 polypeptides as well as the two major isoforms (30 and 32 kDa) exist in the brain and many other tissues agrees with this conclusion. This suggests that different AQP4 isoforms may play a role in the formation and distribution of AQP4-containing orthogonal arrays or in their trafficking.
A transgenic null mouse lacking AQP4 has been generated recently (48) . According to the data, no abnormalities in neuromuscular function were observed in homozygous AQP4 knockout mice, indicating that AQP4 could not play a key role in the regulation of water homeostasis in the neuromuscular system. More recently, the same group reported that AQP4 null mice manifested less brain edema after water intoxication and stroke, pointing to a role played by AQP4 in pathological situations that determine brain edema (49) . However, the possibility that another unknown water channel may be induced when AQP4 is absent as in transgenic null mouse cannot be ruled out. This is a consistent hypothesis, since it has been reported that the last cloned water channel (AQP9) seems to be expressed in brain astrocytes (50) . A preliminary immunolocalization study performed by us confirms that AQP9 is expressed in brain GFAP positive cells (unpublished observation), indicating that this aspect needs to be studied in AQP4 null mice.
In conclusion, mdx mice manifest a reduction in AQP4 expression in muscle and brain. This reduction is age related; in the brain it is associated with swollen perivascular astrocyte processes. We suppose that some neurological dysfunctions of mdx mice and DMD patients could be associated with changes in brain osmotic equilibrium.
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